Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | farnesyltransferase, CAAX box, alpha | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.8 uM | In vitro inhibition of farnesyltransferase farnesylation of the H-ras oncogene | ChEMBL. | 9526562 |
IC50 (binding) | = 3.8 uM | In vitro inhibition of farnesyltransferase farnesylation of the H-ras oncogene | ChEMBL. | 9526562 |
IC50 (binding) | > 20 uM | Inhibition of Farnesyltransferase from Ras-CVLS or Ras-CVLL in Cos-7 monkey kidney cells | ChEMBL. | 9526562 |
IC50 (binding) | > 20 uM | Inhibition of Farnesyltransferase from Ras-CVLS or Ras-CVLL in Cos-7 monkey kidney cells | ChEMBL. | 9526562 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.